The Efficacy of Vildagliptin Concomitant With Insulin Therapy in Type 2 Diabetic Subjects

BACKGROUND: In Japan, dipeptidyl peptidase 4 (DPP4) inhibitors have become standard therapeutic agents for type 2 diabetes, and numbers of patients receiving insulin therapy combined with DPP4 inhibitors, which is a highly effective regimen, are increasing. METHODS: In this study, we evaluated the e...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Med Res
Glavni autori: Ito, Daisuke, Inoue, Kazuyuki, Kaneko, Kimie, Yanagisawa, Morifumi, Sumita, Takashi, Ikegami, Yuichi, Awata, Takuya, Ishida, Hitoshi, Katayama, Shigehiro, Inukai, Kouichi
Format: Artigo
Jezik:Inglês
Izdano: Elmer Press 2015
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356089/
https://ncbi.nlm.nih.gov/pubmed/25780477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2057w
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items